CAS: 96-84-4; 2-(3-Hydroxy-2,4,6-Triiodobenzyl)Butanoic Acid

该化合物是一种三碘芳香化合物,其特点是碘含量高,结构稳定.三个碘原子的存在增强了其放射性,使其适合用于医疗成像的对比介质应用.乙基和氢氧化替代成分有助于其溶解性特征,允许在水或有机系统中配制多功能性.其芳香脊柱在生理条件下确保化学稳健性.该化合物因其在保持低毒性的同时提供清晰的成像对比,达到严格的制药和诊断标准的能力而特别受到重视.由于其含碘成分,需要妥善处理.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

Rac-2-(3-Methoxybenzyl)Butanoic Acid 177362-57-1

合成工艺路线路线简述

    📜2-甲基丁酸置于sodium Phosphate Dibasic Dodecahydrate,N-乙酰-β-丙氨酸,Palladium Diacetate,碳酸氢钠,Silver(L) Oxide体系中,用 甲醇,二氯甲烷 作为反应溶剂,化学反应 17.17H,反应生成 碘芬酸
    参考文献:Pd催化的丙酸和相关脂肪酸的β-C(sp3)-H芳基化
    标题:Pd催化的丙酸和相关脂肪酸的β-C(sp3)-H芳基化
    摘要:据报道,丙酸和相关的α-支链脂肪酸的β-C(sp 3)-H芳基化反应普遍采用钯催化方案.通过使用n-乙酰基-β-丙氨酸作为配体,我们的方案可提供多种芳基化产物.值得注意的是,具有挑战性的底物丙酸可以通过合成获得有用的收率,而丙酸由于其索普-英戈尔德效应而没有任何加速作用,因此可以用作底物.此外,还演示了该协议的可伸缩性和综合适用性.
    DOI:10.1002/chem.201705449

    海关参考信息

    专利信息


    专利号:US-8420850-B2
    优先权日:2010-05-14
    标 题:Compounds for the synthesis of biostable polyurethane, polyurea or polyurea urethane polymers
    发明人:DUOCASTELLA CODINA LLUIS; MOLINA MARIA; ARAD OFIR; BORRELL BILBAO JOSE IGNACIO; GARCIA DAVID SANCHEZ; PETTERSON SALOM SOFIA HENRIETTE
    权利人:DUOCASTELLA CODINA LLUIS; MOLINA MARIA; ARAD OFIR; BORRELL BILBAO JOSE IGNACIO; GARCIA DAVID SANCHEZ; PETTERSON SALOM SOFIA HENRIETTE; IBERHOSPITEX SA
    摘要:The invention comprises compounds which are derived from a drug or a substance with therapeutic properties, and useful as reagents for the synthesis of biostable polymers including said drug in their backbone, namely polyurethanes, polyureas or polyurea urethanes that are biocompatible and biostable. The invention also comprises the processes for preparing the compounds and the polymers, and to the use of these polymers for the manufacture of medical devices.

    专利号:US-2011104052-A1
    优先权日:2007-12-03
    标 题 :Methods of synthesis and use of chemospheres
    发明人:BARNETT BRADLEY POWERS; GESCHWIND JEFFREY
    权利人:UNIV JOHNS HOPKINS
    摘要:The present invention provides, in general, compositions comprising a hydrogel and an agent, for example a therapeutic agent or an imaging agent, for locoregional delivery. In certain preferred embodiments of the invention, the hydrogel compositions are detectable by Magnetic Responance and CT Scan and are used for locoregional delivery of therapeutic agents, for example chemotherapeutic agents. The invention also features polymer matrix compositions comprising nanoparticles that can be loaded after polymerization with bioactive agents, for example a diagnostic agent or therapeutic agent.

    专利号:US-2012059117-A1
    优先权日:2010-05-14
    标 题 :Compounds for the synthesis of biostable polyurethane, polyurea or polyurea urethane polymers

    专利号:WO-2011141341-A1
    优先权日:2010-05-14
    标题:Compounds for the synthesis of biostable polyurethane, polyurea or polyurea urethane polymers

    专利号:EP-2569015-A1
    优先权日:2010-05-14
    标题 :Compounds for the synthesis of biostable polyurethane, polyurea or polyurea urethane polymers

    专利号:CN-101812108-B
    优先权日:2009-11-26
    标 题 :Synthesis of Hydrocortisone Butyrate

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Journal of the American Pharmaceutical Association, Scientific Edition., 42(476), 1953
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知